In a 68-year-old male with a history of smoking and moderate coronary artery disease, what is the recommended treatment and workup?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Recommended Treatment and Workup for 68-Year-Old Male Smoker with Moderate CAD

This patient requires immediate smoking cessation, aspirin 81 mg daily, high-intensity statin therapy targeting LDL <70 mg/dL, blood pressure control to <130/80 mmHg, and consideration of beta-blocker and ACE inhibitor therapy, along with risk stratification through stress testing if symptomatic. 1, 2

Immediate Medical Therapy (Mandatory)

Antiplatelet Therapy

  • Aspirin 75-100 mg daily indefinitely - This is a Class I, Level A recommendation for all patients with coronary artery disease 1, 3
  • Low-dose aspirin (81 mg) is preferred over higher doses to minimize bleeding risk while maintaining cardiovascular protection 4

Lipid Management

  • High-intensity statin therapy initiated immediately, targeting LDL cholesterol <100 mg/dL as a minimum, with LDL <70 mg/dL strongly recommended given his smoking history and established CAD (Class I, Level A) 4, 2
  • The 2019 ESC guidelines specifically recommend aggressive lipid lowering in patients with established CAD, and this patient qualifies as "very high-risk" due to his smoking history combined with moderate CAD 2

Blood Pressure Control

  • Target blood pressure <130/80 mmHg through lifestyle modification and pharmacotherapy as needed (Class I, Level A) 4, 3
  • Measure blood pressure at every visit 1

Beta-Blocker Therapy

  • Beta-blockers should be strongly considered as first-line antianginal therapy, particularly if the patient has any history of myocardial infarction or left ventricular dysfunction (Class I, Level A) 1, 2
  • Even without these conditions, beta-blockers are effective for symptom control and have prognostic benefit 2

ACE Inhibitor or ARB

  • ACE inhibitor therapy is recommended (Class IIa, Level A) in all patients with CAD, particularly those with hypertension, diabetes, or left ventricular dysfunction 2, 3
  • ARB is an acceptable alternative if ACE inhibitor is not tolerated 2, 3

Critical: Smoking Cessation (Highest Priority)

Smoking cessation is the single most effective secondary prevention measure and must be aggressively pursued (Class I, Level A) 1, 3

Specific Smoking Cessation Strategy:

  • Advise complete cessation at every visit 1, 3
  • Nicotine replacement therapy is safe in patients with coronary artery disease and should be offered (Class I, Level A) 1, 3
  • Bupropion is effective and recommended (Class I, Level B) 3
  • Tailor strategies to individual circumstances - no single approach works for all patients 1
  • Avoid e-cigarettes - they have not been proven safe in vascular disease and may impair endothelial function 5

Risk Stratification and Workup

If Asymptomatic:

  • Routine periodic stress testing is not recommended in asymptomatic patients (Class III: No Benefit) 4
  • Periodic cardiovascular follow-up to reassess risk factors, lifestyle modifications, and development of symptoms (Class I, Level C) 2

If Symptomatic (Angina or Dyspnea):

  • Stress imaging (echocardiography or perfusion scintigraphy) is preferred over exercise ECG alone for risk stratification (Class I, Level B) 2
  • Exercise ECG is acceptable if stress imaging unavailable 1
  • Perform testing on the patient's usual medications to assess real-world symptom control 1

Consider Invasive Coronary Angiography (with FFR when necessary) if:

  • Symptoms refractory to medical therapy 2
  • High-risk features on non-invasive testing 2
  • Significant worsening of symptoms 2

Additional Mandatory Interventions

Lifestyle Modifications

  • Mediterranean diet emphasizing fruits, vegetables, fish, and limiting saturated fats and salt (Class I, Level B) 3
  • Weight reduction if BMI ≥30 kg/m² or waist circumference ≥102 cm (Class I, Level B) 1, 3
  • Regular moderate-intensity aerobic exercise at least 5 times per week (Class I, Level B) 3
  • Consider medically supervised cardiac rehabilitation program for moderate-to-high risk patients (Class I, Level A) 4

Sublingual Nitroglycerin

  • Prescribe for use as needed in response to angina and prophylactically before activities that trigger symptoms (Class I, Level C) 1

Additional Monitoring

  • Measure serum cholesterol to guide statin therapy (Class I, Level A) 1
  • Screen for and manage diabetes if present 4, 2
  • Annual influenza vaccination (Class I, Level B) 3

Common Pitfalls to Avoid

  1. Do not delay statin therapy waiting for lipid levels - initiate immediately in all CAD patients 3
  2. Do not abruptly discontinue beta-blockers - taper over 4 weeks if discontinuation necessary 1
  3. Do not perform routine annual stress testing in stable, asymptomatic patients - this is not evidence-based and may lead to unnecessary interventions 4
  4. Do not use nitrate patches continuously - ensure nitrate-free interval to avoid tolerance (Class I, Level A) 1
  5. Do not underestimate the importance of smoking cessation - it reduces mortality by at least one-third and is more effective than most pharmacologic interventions 3

Follow-Up Strategy

  • Reassess symptoms, medication adherence, side effects, and risk factor control at regular intervals 2
  • Ensure patient understands warning signs of acute coronary syndrome requiring immediate evaluation 2
  • Coordinate care with primary care physician for comprehensive management of comorbidities 4, 2

References

Related Questions

For patients able to exercise with a normal resting electrocardiogram, is an exercise treadmill stress test preferred over a two‑dimensional echocardiogram with Doppler as the initial screening test for coronary artery disease?
What is the recommended management for an adult with established coronary artery disease and typical risk factors such as hypertension, hyperlipidemia, diabetes, smoking, or a family history of premature heart disease?
What is the recommended management for coronary artery disease?
What is the appropriate initial evaluation and management for a 61-year-old male presenting with chest pain and a history of coronary artery disease?
What is the nutritional content of agave syrup and is it safe for a patient with cardiovascular disease?
How should ectopic atrial beats be managed in a stable patient without structural heart disease, ischemia, or heart failure?
How is the basal insulin dose calculated for an adult with type 1 diabetes?
When is it appropriate to transition intravenous ceftriaxone to oral therapy, and which oral β‑lactam agents are suitable for the switch?
For a patient on insulin glargine (Lantus) 6 units who now has a fasting blood glucose of 68 mg/dL, how should the basal insulin dose be adjusted and what should the insulin‑sensitivity factor (ISF) and insulin‑to‑carbohydrate ratio (ICR) be?
How do diuretics decrease blood urea nitrogen (BUN) levels?
Can a patient with a history of aplastic anemia safely continue escitalopram and mirtazapine for depression, and what CBC monitoring schedule is recommended?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.